Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Amgen Inc

Sanofi

F. Hoffmann-La Roche Ltd

Novartis AG

AbbVie Inc

Takeda Pharmaceutical Co Ltd

Bayer AG

Pfizer Inc

Astellas Pharma Inc

Abbott Laboratories

Amgen Inc

Sanofi

F. Hoffmann-La Roche Ltd

Novartis AG

AbbVie Inc

Takeda Pharmaceutical Co Ltd

Bayer AG

Pfizer Inc

Astellas Pharma Inc

Abbott Laboratories

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on Chronic Kidney Disease (Chronic Renal Failure) 40

Apr 01, 2019: Proteon Therapeutics’ vonapanitase fails in Phase III trial 40

Mar 28, 2019: Tricida announces positive results from long-term clinical trial of TRC101 in patients with CKD and metabolic acidosis 40

Mar 28, 2019: Janssen submits Supplemental New Drug Application to U.S. FDA for INVOKANA (canagliflozin) for the treatment of chronic kidney disease in patients with type 2 diabetes 41

Mar 27, 2019: Tricida to report long-term clinical trial results for TRC101 in CKD patients with metabolic acidosis and host conference call and webcast on Thursday, March 28, 2019 41

Mar 18, 2019: Rockwell Medical Announces I.V. triferic and peritoneal dialysis study abstracts selected as best-in-category at the Annual Dialysis Conference 42

Mar 11, 2019: Tricida announces publication of positive TRC101 pivotal trial results in The Lancet 42

Feb 14, 2019: DiaMedica Therapeutics doses first patient in phase 1b clinical study of DM199 in patients with chronic kidney disease 43

Jan 24, 2019: Proteon Therapeutics announces publication of results from phase 3 PATENCY-1 clinical trial of investigational Vonapanitase in patients with chronic kidney disease 44

Clinical Trial Profile Snapshots 45

Appendix 1577

Abbreviations 1577

Definitions 1577

Research Methodology 1578

Secondary Research 1578

About GlobalData 1579

Contact Us 1579

Source 1580

List of Tables

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and ...

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 22

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase, 2019* 27

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and ...

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 22

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

GlobalData Methodology 1578

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports